Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. (ADHAESIONE)

Universidad de Murcia

Status: Unknown

Conditions: Haemophilia

Study type: Observational

Funder types: Other

Identifiers

NCT02197611

Haemo-Adhaesione (Other Identifier)

Haemo Adhaesione

Details and patient eligibility

About

Research project for the development, construction and validation of a questionnaire of adherence to treatment in adult patients with hemophilia. It aims to build a scale according to five relevant dimensions of adherence to treatment: 1) physician-patient relationship, 2) knowledge of the disease, 3) previous bleeding problems, 4) knowledge of future consequences and difficulties, and 5) benefits of treatment.

Full description

• Descriptive study for the construction of a multidimensional scale of adherence to treatment in adult patients with hemophilia.
• Validation of a scale specific measure for patients with hemophilia that includes 5 dimensions that may affect adherence to treatment: a) the doctor-patient, b) regarding knowledge of the disease, c) the previous hemorrhages, d) knowledge future sequels, e) difficulties with treatment.
• Statistical and psychometric analysis of the adherence questionnaire for adult patients with hemophilia.
• Description of the theoretical framework that justifies the completion of the questionnaire, and the choice of the dimensions and items that make up the measurement scale.
• The questionnaire obtained in this project will identify the actual degree of patient adherence to multidisciplinary treatment, taking as gold standard, compliance with pharmacological treatment (the difference between the treatment prescribed and consumed).

Enrollment: 100 estimated patients

Sex: Male

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with hemophilia A or B.
• Patients over 18 years of age.

Exclusion criteria

• Patients with neurological or cognitive impairments that hinder oral and written comprehension.
• Patients who have not signed the informed consent document

Trial design

100 participants in 1 patient group

Validation group

Description:

Group of patients who we will consult the characteristics of the scale designed and will be made the statistical calculations of validity, reliability and reproducibility